Fiocruz – AstraZeneca, COVID-19 Technological Order Agreement

Provision Language

<p><span style=”text–decoration: underline;”><b>1. Object and Territoryb>span>p>
<p>[&#8230;]p>
<p><strong>1.6.3strong> Within up to thirty (30) days from the present date, the Parties shall enter into Exhibit VI &#8211; Regulatory Activities Agreement, with the objective of, among others, disciplining the interaction of the Parties in relation to the Covid–19 Vaccine registration strategy with the National Agency Health Surveillance (“<b><i>ANVISAi>b><i>”i>).p>